Abbott | ABT - Eigenkapital Und Reserven

Aktienkurs
105.56
Täglich Wechseln
-1.63 -1.52%
Monatlich
-8.44%
Jährlich
-16.45%
Q1 Prognose
104.77




Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.13B 1.3B 2025-12
Agilent USD 6.91B 167M 2025-12
AtriCure USD 491.94M 15.43M 2025-12
Baxter International USD 6.13B 1.11B 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bio-Rad Laboratories USD 7.45B 716.8M 2025-12
Boston Scientific USD 24.23B 1.58B 2025-12
Cooper Companies USD 8.36B 124.7M 2025-12
Danaher USD 52.53B 1.46B 2025-12
Dexcom USD 2.75B 19.9M 2025-12
Edwards Lifesciences USD 10.2B 340.3M 2025-09
Globus Medical USD 4.57B 174.42M 2025-12
Hologic USD 5.25B 197.2M 2025-12
Insulet USD 1.52B 131.1M 2025-12
Integra LifeSciences USD 1.04B 5.89M 2025-12
Intuitive Surgical USD 17.82B 894.3M 2025-12
J&J USD 78.47B 0 2025-09
Masimo USD 721.2M 88.8M 2025-12
Medtronic USD 48.99B 128M 2025-12
Merit Medical Systems USD 1.58B 54.9M 2025-12
Pfizer USD 92.8B 4.11B 2025-09
Smith & Nephew USD 5.54B 331M 2025-12
Solventum Corp USD 5.05B 63M 2025-12
Stryker USD 21.78B 594M 2025-09
Tandem Diabetes Care USD 155.17M 22.2M 2025-12
Teleflex USD 3.12B 697.09M 2025-12
Terumo JPY 1.52T 84.79B 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Zimmer Biomet Holdings USD 12.7B 68.3M 2025-12